In order to respond to the impact of the public health crisis, the ERDF investment priority to strengthen research, technological development and innovation should cover investment in products and services necessary for fostering crisis response capacities in health services.
Recital 4, Regulation (EU) 2020/460
In forcesince 30 Mar 2020